Seul Gi Lee

Randomized Controlled Trial: Subcutaneous versus Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease.

Sang Joon Lee, W. Reinisch, J. Kierkuś, 2021, Gastroenterology.